Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)

Ocular Therapeutix has reported Other Operating Expenses for 14 years, with the latest figure at $19.3 million in Q2 2026.

• Other Operating Expenses for Q2 2026 came in at $19.3 million, up 66406.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $51.7 million (up 30.52% YoY), and the FY2025 annual result was $60.5 million, up 28.13% from the prior year.
• Other Operating Expenses grew to $19.3 million in Q2 2026, from $17.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $19.3 million in Q2 2026 and troughed at $29000.0 in Q2 2025.
• A 5-year average of $12.0 million and a median of $11.5 million in 2022 frame the typical range for Other Operating Expenses.
• The widest annual swing landed in 2025, when Other Operating Expenses tumbled 99.75%; it then surged 66406.9% in 2026.
• A 5-year view of Other Operating Expenses shows it stood at $11.5 million in 2022, then slipped by 7.91% to $10.6 million in 2023, then gained by 13.54% to $12.1 million in 2024, then climbed by 20.56% to $14.6 million in 2025, then jumped by 32.55% to $19.3 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $19.3 million in Q2 2026, $17.9 million in Q1 2026, and $14.6 million in Q4 2025.